英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

silvan    
a. 森林的,乡村的
n. 森林之神

森林的,乡村的森林之神

silvan
adj 1: relating to or characteristic of wooded regions; "a shady
sylvan glade" [synonym: {sylvan}, {silvan}]
n 1: a spirit that lives in or frequents the woods [synonym:
{sylvan}, {silvan}]


请选择你想看的字典辞典:
单词字典翻译
silvan查看 silvan 在百度字典中的解释百度英翻中〔查看〕
silvan查看 silvan 在Google字典中的解释Google英翻中〔查看〕
silvan查看 silvan 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Libtayo more favorable than Keytruda for first-line . . .
    The FDA approved Libtayo in 2022 as a first-line treatment for advanced NSCLC, in combination with chemotherapy However, it has been unclear whether this new combination treatment could outperform Keytruda plus chemotherapy from a cost-effectiveness standpoint
  • THIO Plus Libtayo Elicits Positive Responses in Advanced . . .
    THIO combined with Libtayo shows improved progression-free survival of 5 6 months versus 2 5 months with standard treatments in advanced non-small cell lung cancer The THIO-101 trial indicates a median overall survival of 17 8 months, highlighting the potential for extended dosing and durability of
  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® (cemiplimab-rwlc) | Official HCP Website
    LIBTAYO® (cemiplimab-rwlc) is a prescription medicine indicated for the treatment of adult patients with advanced NSCLC, CSCC, BCC, and as an adjuvant treatment for high-risk CSCC See Important Safety full Prescribing Information
  • Cemiplimab (Libtayo): A Patient Guide for 2025 to Treatment . . .
    Cemiplimab (Libtayo): A Patient Guide for 2025 to Treatment, Side Effects, Dosage, and Research Cemiplimab is a newer cancer treatment that has brought hope to patients with advanced skin and lung cancers It is part of an exciting group of drugs called immune checkpoint inhibitors, which help the body’s immune system fight cancer more
  • Libtayo (cemiplimab-rwlc): Uses, Side Effects . . . - WebMD
    Libtayo (cemiplimab-rwlc) is commonly used to treat certain types of cancer It is used to treat certain types of skin cancers, including cutaneous squamous cell carcinoma (CSCC) and basal cell





中文字典-英文字典  2005-2009